(Q50767143)

English

Which breast carcinomas need HER-2/neu gene study after immunohistochemical analysis? Results of combined use of antibodies against different c-erbB2 protein domains.

scientific article published in October 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

Which breast carcinomas need HER-2/neu gene study after immunohistochemical analysis? Results of combined use of antibodies against different c-erbB2 protein domains. (English)

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

immunohistochemistry

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

Massimo Bongiovanni

6

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

author name string

Coccorullo Z

2

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

Cassoni P

3

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

Ghisolfi G

4

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

Gugliotta P

5

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

Arisio R

7

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

Crafa P

8

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

Bussolati G

9

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

publication date

1 October 2003

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

43

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

354-362

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

4

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2003.01708.X

21 January 2018

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2003.01708.X

21 January 2018

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2003.01708.X

21 January 2018

Recommendations for HER2 testing in the UK.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2003.01708.X

21 January 2018

Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2003.01708.X

21 January 2018

Chromogenic in situ hybridization analysis of HER-2/neu status in breast carcinoma: application in screening of patients for trastuzumab (Herceptin) therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2003.01708.X

21 January 2018

Amplification of growth regulatory genes in intraductal breast cancer is associated with higher nuclear grade but not with the progression to invasiveness.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2003.01708.X

21 January 2018

HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2003.01708.X

21 January 2018

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2003.01708.X

21 January 2018

Truncated ErbB2 receptor enhances ErbB1 signaling and induces reversible, ERK-independent loss of epithelial morphology

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2003.01708.X

21 January 2018

Identifiers

10.1046/J.1365-2559.2003.01708.X

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/14511254

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50767143&oldid=2107800342"